Publication

Articles and reviews

Articles (since 2016) 

​​

  1. Ueda J†, Bundo M†, Nakachi Y, Kasai K, Kato T*, Iwamoto K*.
    Cell type-specific DNA methylation analysis of the prefrontal cortex of patients with schizophrenia.
    Psychiatry and Clinical Neurosciences, in press
    doi: 10.1111/PCN.13282

     

  2. Kobayashi Y, Inaba H, Iwakura Y, Namba H, Sotoyama H, Murata Y, Iwamoto K, Nawa H*.Inter-breeder differences in prepulse inhibition deficits of C57BL/6J mice in a maternal infection model for schizophrenia.
    Neuropsychopharmacology Reports, in press
    doi: 10.1002/npr2.12178
     

  3. Bundo M†, Ueda J†, Nakachi Y, Kasai K, Kato T*, Iwamoto K*.
    Decreased DNA methylation at promoters and gene-specific neuronal hypermethylation in the prefrontal cortex of patients with bipolar disorder. 
    Molecular Psychiatry in press
    doi: 10.1038/s41380-021-01079-0

     

  4. Maeshiro M, Shinriki S*, Liu R, Nakachi Y, Komohara Y, Fujiwara Y, Ohtsubo K, Yoshida R, Iwamoto K, Nakayama H, Matsui H*.
    Colonization of distant organs by tumor cells generating circulating homotypic clusters adaptive to fluid shear stress.
    Scientific Reports, 11:6150, 2021
    doi: 10.1038/s41598-021-85743-z

     

  5. Ikegame T†, Hidaka Y†, Nakachi Y, Murata Y, Watanabe R, Sugawara H, Asai T, Kiyota E, Saito T, Ikeda M, Sasaki T, Hashimoto M, Ishikawa T, Takebayashi M, Iwata N, Kakiuchi C, Kato T, Kasai K, Bundo M*, Iwamoto K*.
    Identification and functional characterization of the extremely long allele of the serotonin transporter-linked polymorphic region. 
    Translational Psychiatry, 11:119, 2021
    doi: 10.1038/s41398-021-01242-9

     

  6. Wada Y, Maekawa M*, Ohnishi T, Balan S, Matsuoka S, Iwamoto K, Iwayama Y, Ohba H, Watanabe A, Hisano Y, Nozaki Y, Toyota T, Shimogori T, Itokawa M, Kobayashi T, Yoshikawa T*.
    Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia.
    EBioMedicine, 62:103130, 2020
    doi:10.1016/j.ebiom.2020.103130

     

  7. Nakachi Y, Ishii K, Bundo M, Masuda T*, Iwamoto K*.
    Use of the Illumina EPIC methylation array for epigenomic research in the crab-eating macaque (Macaca fascicularis). 
    Neuropsychopharmacology Reports, 40:423-426, 2020
    doi:10.1002/npr2.12145

     

  8. Kuroki R†, Murata Y†, Fuke S, Nakachi Y, Nakashima J, Kujoth GC, Prolla TA, Bundo M, Kato T, Iwamoto K.* Establishment of qPCR assays for active LINE-1 subfamilies in mice and applications to the analysis of aging-associated retrotransposition,
    Frontiers in Genetics, 11:519206, 2020

     

  9. Ikegame T†, Bundo M†, Okada N, Murata Y, Koike S, Sugawara H, Saito T, Ikeda M, Owada K, Fukunaga M, Yamashita F, Koshiyama D, Natsubori T, Iwashiro N, Asai T, Yoshikawa A, Nishimura F, Kawamura Y, Ishigooka J, Kakiuchi C, Sasaki T, Abe O, Hashimoto R, Iwata N, Yamasue H, Kato T, Kasai K, Iwamoto K*.​
    Promoter activity-based case-control association study on SLC6A4 highlighting hypermethylation and altered amygdala volume in male patients with schizophrenia.
    Schizophrenia Bulletin, 46:1577-1586, 2020

     

  10. Murata Y, Ikegame T, Koike S, Saito T, Ikeda M, Sasaki T, Iwata N, Kasai K, Bundo M*, Iwamoto K*.
    Global DNA hypomethylation and its correlation to the betaine level in peripheral blood of patients with schizophrenia.
    Progress in Neuropsychopharmacology & Biological Psychiatry, 99:109855, 2020.

     

  11. Zhao Z, Jinde S*, Koike S, Tada M, Satomura Y, Yoshikawa A, Nishimura Y, Takizawa R, Kinoshita A, Sakakibara E, Sakurada H, Yamagishi M, Nishimura F, Inai A, Nishioka M, Eriguchi Y, Araki T, Takaya A, Kan C, Umeda M, Shimazu A, Hashimoto H, Bundo M, Iwamoto K, Kakiuchi C, Kasai K.
    Altered expression of microRNA-223 in the plasma of patients with first-episode schizophrenia and its possible relation to neuronal migration-related genes.
    Translational Psychiatry, 9:289, 2019.

     

  12. Ide M†, Ohnishi T†, Toyoshima M, Balan S, Maekawa M, Shimamoto-Mitsuyama C, Iwayama Y, Ohba H, Watanabe A, Ishii T, Shibuya N, Kimura Y, Hisano Y, Murata Y, Hara T, Morikawa M, Hashimoto K, Nozaki Y, Toyota T, Wada Y, Tanaka Y, Kato T, Nishi A, Fujisawa S, Okano H, Itokawa M, Hirokawa N, Kunii Y, Kakita A, Yabe H, Iwamoto K, Meno K, Katagiri T, Dean B, Uchida K, Kimura H, Yoshikawa T*.
    Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology.
    EMBO Molecular Medicine, e10695, 2019.

     

  13. Murata Y†, Fujii A†, Kanata S, Fujikawa S, Ikegame T, Nakachi Y, Zhao Z, Jinde S, Kasai K, Bundo M*, Iwamoto K*.
    Evaluation of the usefulness of saliva for DNA methylation analysis in cohort studies.
    Neuropsychopharmacology Reports, 39:301-305, 2019.

     

  14. Okada N, Ando S, Sanada M, Hirata‐Mogi S, Iijima Y, Sugiyama H, Shirakawa T, Yamagishi M, Kanehara A, Morita M, Yagi T, Hayashi N, Koshiyama D, Morita K, Sawada K, Ikegame T, Sugimoto N, Toriyama R, Masaoka M, Fujikawa S, Kanata S, Tada M, Kirihara K, Yahata N, Araki T, Jinde S, Kano Y, Koike S, Endo K, Yamasaki S, Nishida A, Hiraiwa‐Hasegawa M, Bundo M, Iwamoto K, Tanaka SC, Kasai K*. The population‐neuroscience study of the Tokyo TEEN Cohort (pn‐TTC): a cohort longitudinal study to explore the neurobiological substrates of adolescent psychological and behavioral development.
    Psychiatry and Clinical Neurosciences, 73:231-242, 2019.

     

  15. Murata Y, Bundo M*, Sunaga F, Kasai K, Iwamoto K*.
    DNA methylation profiling in a neuroblastoma cell line exposed to the antipsychotic perospirone.
    Pharmacopsychiatry, 52:63-69, 2019.

     

  16. Nishioka M, Bundo M, Ueda J, Yoshikawa A, Nishimura F, Sasaki T, Kakiuchi C, Kasai K, Kato T*, Iwamoto K*.
    Identification of somatic mutations in monozygotic twins discordant for psychiatric disorders.
    npj Schizophrenia, 4:7, 2018.
    doi: 10.1038/s41537-018-0049-5

     

  17. Miura I*, Kunii Y, Hino M, Hoshino H, Matsumoto K, Kanno-Nozaki K, Horikoshi S, Kaneko H, Bundo M, Iwamoto K, Yabe H.
    DNA methylation of ANKK1 and response to aripiprazole in patients with acute schizophrenia: A preliminary study.
    Journal of Psychiatric Research, 100:84-87, 2018.

     

  18. Sugawara H, Murata Y, Ikegame T, Sawamura R, Shimanaga S, Takeoka Y, Saito T, Ikeda M, Yoshikawa A, Nishimura F, Kawamura Y, Kakiuchi C, Sasaki T, Iwata N, Hashimoto M, Kasai K, Kato T, Bundo M*, Iwamoto K*.
    DNA methylation analyses of the candidate genes identified by a methylome-wide association study revealed common epigenetic alterations in schizophrenia and bipolar disorder.
    Psychiatry and Clinical Neurosciences, 72:245-254, 2018.

     

  19. Shimada-Sugimoto M, Otowa T*, Miyagawa T, Umekage T, Kawamura Y, Bundo M, Iwamoto K, Ikegame T, Tochigi M, Kasai K, Kaiya H, Tanii H, Okazaki Y, Tokunaga K, Sasaki T.
    An epigenome-wide methylation study of healthy individuals with or without depressive symptoms.
    Journal of Human Genetics​, 63:319-326, 2018.

     

  20. Nishioka M, Bundo M, Ueda J, Katsuoka F, Sato Y, Kuroki Y, Ishii T, Ukai W, Murayama S, Hashimoto E, Nagasaki M, Yasuda J, Kasai K, Kato T*, Iwamoto K​*.
    Identification of somatic mutations in postmortem human brains by whole genome sequencing and their implications for psychiatric disorders.
    Psychiatry and Clinical Neurosciences, 72:280-294, 2018.

     

  21. Yoshikawa A, Nishimura F, Inai, A, Eriguchi, Y, Nishioka, M, Takaya A, Tochigi M, Kawamura Y, Umekage T, Kato K, Sasaki T, Ohashi Y, Iwamoto K, Kasai K, Kakiuchi C*.
    Mutations of the glycine cleavage system genes possibly affect the negative symptoms of schizophrenia through metabolomic profile changes.
    Psychiatry and Clinical Neurosciences, 72:168-179, 2018.

     

  22. Murata Y, Bundo M, Ueda J, Kubota-Sakashita M, Kasai K, Kato T, Iwamoto K*.
    DNA methylation and hydroxymethylation analyses of the active LINE-1 subfamilies in mice.
    Scientific Reports, 7:13624, 2017.

     

  23. Maekawa M, Watanabe A, Iwayama Y, Kimura T, Hamazaki K, Balan S, Ohba H, Hisano Y, Nozaki Y, Ohnishi T, Toyoshima M, Shimamoto C, Iwamoto K, Bundo M, Osumi N, Takahashi E, Takashima A, Yoshikawa T*.
    Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes.
    Translational Psychiatry, 7:e1229, 2017.

     

  24. Ueda J†, Murata Y†, Bundo M, Oh-Nishi A, Kassai H, Ikegame T, Zhao Z, Jinde S, Aiba A, Suhara T, Kasai K, Kato T, Iwamoto K*.
    Use of human methylation arrays for epigenome research in the common marmoset (Callithrix jacchus).
    Neuroscience Research, 120:60-65, 2017.

     

  25. Shimada-Sugimoto M, Otowa T*, Miyagawa T, Umekage T, Kawamura Y, Bundo M, Iwamoto K, Tochigi M, Kasai K, Kaiya H, Tanii H, Okazaki Y, Tokunaga K, Sasaki T.
    Epigenome-wide association study of DNA methylation in panic disorder.
    Clinical Epigenetics, 9:6, 2017.

     

  26. Kasahara T, Ishiwata M, Kakiuchi C, Fuke S, Iwata N, Ozaki N, Kunugi H, Minabe Y, Nakamura K, Iwata Y, Fujii K, Kanba S, Ujike H, Kusumi I, Kataoka M, Matoba N, Takata A, Iwamoto K, Yoshikawa T, Kato T*.
    Enrichment of deleterious variants of mitochondrial DNA polymerase gene (POLG1) in bipolar disorder.
    Psychiatry and Clinical Neurosciences, 71:518-529, 2017.

Reviews and book chapters (since 2016) 

  1. Nishioka M, Bundo M, Iwamoto K*, Kato T*. 
    Somatic mutations in the human brain: implications for psychiatric research.
    Molecular Psychiatry, 24:839-856, 2019.
    doi: 10.1038/s41380-018-0129-y

     

  2. Iwamoto K*. 
    Understanding the epigenetic architecture of psychiatric disorders: modifications and beyond.
    Psychiatry and Clinical Neurosciences, 72:194, 2018.

    doi: 10.1111/pcn.12646
     

  3. Bundo M*, Kato T, Iwamoto K.
    Estimation of LINE-1 Copy Number in the Brain Tissue and Isolated Neuronal Nuclei.
    In: Frade J., Gage F. (eds) Genomic Mosaicism in Neurons and Other Cell Types. 
    Neuromethods, 2017 vol 131. Humana Press, New York, NY